Clinical Trials
113 trialsadIVO
Institut für Klinische Krebsforschung IKF GmbH at Krankenhaus Nordwest
Intravital Microscopy in Human Solid Tumors
Mayo Clinic
Trop2-targeted immunoPET Imaging of Solid Tumors
RenJi Hospital
Safety and Efficacy of CD160-Enhanced Autologous Antigen-Specific T-Cells (BTC-Ag-T) in Advanced Biliary Tract Cancer
Shanghai Zhongshan Hospital
TRACK
TargetCancer Foundation
SEVILLA
UNICANCER
Pemigatinib + Afatinib in Advanced Refractory Solid Tumors
Massachusetts General Hospital
18F-T2 PET/CT Imaging for CAIX Positive Solid Tumors
Peking University First Hospital
Radioembolization With Tremelimumab and Durvalumab for Locally Advanced Unresectable or Oligo-Metastatic Intrahepatic Cholangiocarcinoma
Mayo Clinic
ELEGANCE
Nantes University Hospital
A Phase 1 Dose-escalation Trial of KST-6051 in Participants With Advanced Solid Tumors With Kirsten Rat Sarcoma Viral Oncogene Homolog (KRAS) Mutation
Kestrel Therapeutics, Inc.
A Phase II Study of Pemigatinib Plus Durvalumab in Previously Treated Advanced Intrahepatic Cholangiocarcinoma Patients With FGFR-2 Fusion or Rearrangement
Hoosier Cancer Research Network
Chidamide Combined With Chemotherapy and Immunotherapy as First-line Treatment for Advanced Intrahepatic Cholangiocarcinoma
Shanghai Zhongshan Hospital
Phase II Study of Neoadjuvant Tislelizumab Plus Radiotherapy and GP Chemotherapy for Borderline/Unresectable Hilar Cholangiocarcinoma
Shandong Cancer Hospital and Institute
FAPDIG
University Hospital, Bordeaux
Map HPB
University of Nottingham
Gemcitabine and Oxaliplatin Chemotherapy With or Without a Floxuridine and Dexamethasone Pump in People With Cholangiocarcinoma That Cannot Be Removed With Surgery
Memorial Sloan Kettering Cancer Center
Y-90 With Durvalumab/Gem/Cis in Intrahepatic Cholangio
Beth Israel Deaconess Medical Center
Modified Immune Cells (Autologous Dendritic Cells) and a Vaccine (Prevnar) Combined With Immune Checkpoint Inhibition After High-Dose External Beam Radiation Therapy in Treating Patients With Unresectable Liver Cancer
Mayo Clinic
Molecular Epidemiology of Biliary Tree Cancers
M.D. Anderson Cancer Center
A Single-Arm Study of Pembrolizumab With Gemcitabine and Cisplatin as Perioperative Therapy for Potentially Resectable Intrahepatic Cholangiocarcinoma
M.D. Anderson Cancer Center
LASER
Seoul National University Hospital
ANTARES
Instituto do Cancer do Estado de São Paulo
RIS-TH
Assistance Publique - Hôpitaux de Paris
ELUCIDATE
City of Hope Medical Center
Liver Transplantation in Intrahepatic Cholangiocarcinoma
Rutgers, The State University of New Jersey
Investigation of Predictive Biomarkers in Patients With Advanced BTC Treated With Lenvatinib Plus Pembrolizumab
CHA University
Frequency and Clinical Phenotype of BAP1 Hereditary Predisposition Syndrome
Ohio State University
HAIC-quad
West China Hospital
OLIGOMETS
Yale University
Pilot Comparing ctDNA IDV vs. SPV Sample in Pts Undergoing Biopsies for Hepatobiliary and Pancreatic Cancers
University of California, Irvine
Trifluridine/Tipiracil + Oxaliplatin in Participants With Advanced or Metastatic Biliary Tract Cancer
Case Comprehensive Cancer Center
Biobank for Cholestatic Liver Diseases.
Mayo Clinic
Characterization of Biliary Cell-derived Organoids From Bile of PSC and Non-PSC Patients
Mayo Clinic
REGULUS: MRI-guided Adaptive SABR for Liver Cancers
Stanford University
Study of Safety/Feasibility of a Hybrid Model of Tertiary and Community Delivery of Hepatic Artery Infusion Chemotherapy
University of Kentucky
TOMCAT
Oslo University Hospital
Study of Gemcitabine, Cisplatin, AB680 and AB122 During First Line Treatment of Advanced Biliary Tract Cancers (QUIC)
Big Ten Cancer Research Consortium
Laryngopharyngeal Injury After Endotracheal Intubation Under General Anesthesia
Zhejiang University
BRAVE
Aichi Medical University
FAPi-2
Tata Memorial Centre
Anti-PD-1/PD-L1 Antibodies Plus Gemcitabine and Cisplatin for Advanced CCA
Shanghai Zhongshan Hospital
PULSAR Combined With Immunotherapy and Chemotherapy
West China Hospital
PROTEOBILE
University Hospital, Bordeaux
Chemoimmunotherapy Combined With Hyperthermia and Spatially-Fractionated Radiotherapy in Advanced Biliary Tract Cancer
University of Maryland, Baltimore
Mechanistic Study on the Protective and Regenerative Effects of Spirulina in Hepatectomy-Related Liver Injury
Second Affiliated Hospital, School of Medicine, Zhejiang University
Durvalumab + Intraductal Radiofrequency Ablation (ID-RFA) in Extrahepatic Cholangiocarcinoma
Institut für Klinische Krebsforschung IKF GmbH at Krankenhaus Nordwest
ACADEMY
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University
MiGIC
City of Hope Medical Center
A Study of GV20-0251 in Advanced or Refractory Solid Tumors
West China Hospital